Target intelligence / Profile preview

Extracellular matrix and associated cell-surface partners (ECM)

Target
ECM
Molecular classification
Extracellular matrix, Cell adhesion molecule, Structural protein, Glycoprotein, Proteoglycan
01

Overview

The extracellular matrix (ECM) and associated cell-surface partners represent a vast network of extracellular macromolecules and their corresponding receptors that provide structural and functional integrity to tissues (Frantz et al., 2010, J Cell Sci). This complex assembly, often referred to as the matrisome, includes core components like collagens, elastins, and laminins, as well as associated receptors such as integrins and syndecans that bridge the extracellular environment to the intracellular cytoskeleton (Hynes & Naba, 2012, Cold Spring Harb Perspect Biol). Beyond providing a physical scaffold, the ECM serves as a dynamic signaling hub that regulates essential cellular processes including survival, proliferation, and migration by sequestering growth factors and transducing mechanical cues (Reactome, R-HSA-1474244). In disease states, the ECM is often pathologically remodeled; for instance, excessive deposition leads to fibrosis, while enzymatic degradation facilitates cancer cell invasion and metastasis (Lu et al., 2012, J Cell Biol). Although the ECM is a broad biological category rather than a single molecular entity, its individual constituents are high-value therapeutic targets for a wide range of clinical indications, from cardiovascular disease to oncology (Naba et al., 2016, BMC Cancer).

Other names
Extracellular matrixMatrisomeECM-associated proteinsCell-matrix interactomeExtracellular matrix organization
02

Mechanism of action

Modulation of cell-matrix adhesion, enzymatic degradation of structural components, and inhibition of integrin-mediated signaling.

03

Biological functions

Cell adhesionSignal transductionStructural supportTissue remodelingGrowth factor sequestrationCell migration
04

Disease associations

CancerFibrosisCardiovascular diseaseInflammationGenetic connective tissue disorders
05

Safety considerations

Impaired wound healingIncreased risk of hemorrhageOff-target effects due to ubiquitous expressionTissue integrity compromisePotential for systemic inflammatory response
06

Interacting drugs

Abciximab

5 more in the full profile.

07

Biomarkers

Matrix metalloproteinases (MMPs)C-terminal telopeptide of type I collagen (CTX-I)FibronectinLamininTenascins

Beyond the preview

Go deeper on Extracellular matrix and associated cell-surface partners (ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix and associated cell-surface partners (ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call